Akhina Palollathil
Overview
Explore the profile of Akhina Palollathil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palollathil A, Babu S, Abhinand C, Mathew R, Vijayakumar M, Prasad T
Expert Rev Proteomics
. 2024 Nov;
21(11):483-495.
PMID: 39523852
Objectives: Oral squamous cell carcinoma poses a substantial global health challenge marked by rising mortality rate. Recently, immunotherapy has shown promising results in cancer management by enhancing immune response. Thus,...
2.
Palollathil A, Nandakumar R, Ahmed M, Velikkakath A, Nisar M, Nisar M, et al.
Sci Rep
. 2024 Oct;
14(1):25327.
PMID: 39455682
Drug resistance poses a significant obstacle to the success of anti-cancer therapy in head and neck cancers (HNCs). We aim to develop a platform for visualizing and analyzing molecular expression...
3.
Palollathil A, Najar M, Amrutha S, Pervaje R, Modi P, Prasad T
Neurochem Int
. 2024 Sep;
180:105864.
PMID: 39349220
Alzheimer's disease, a prevalent neurodegenerative disorder in the elderly, is characterized by the accumulation of senile plaques and neurofibrillary tangles, triggering oxidative stress, neuroinflammation, and neuronal apoptosis. Current therapies focus...
4.
Aravind A, Nandakumar R, Ahmed M, Nisar M, Palollathil A, Kanichery A, et al.
Life Sci Alliance
. 2024 May;
7(7).
PMID: 38719747
The differential expression of plasma membrane proteins is integrally analyzed for their diagnosis, prognosis, and therapeutic applications in diverse clinical manifestations. Necessarily, distinct membrane protein enrichment methods and mass spectrometry...
5.
Devasahayam Arokia Balaya R, Palollathil A, Kumar S, Chandrasekaran J, Upadhyay S, Parate S, et al.
Sci Rep
. 2024 Feb;
14(1):3872.
PMID: 38365839
Hemigraphis alternata (H. alternata), commonly known as Red Flame Ivy, is widely recognized for its wound healing capabilities. However, the pharmacologically active plant components and their mechanisms of action in...
6.
Rex D, Suchitha G, Palollathil A, Kanichery A, Keshava Prasad T, Dagamajalu S
J Cell Commun Signal
. 2022 Feb;
16(4):601-608.
PMID: 35174439
Urotensin-II is a polypeptide ligand with neurohormone-like activity. It mediates downstream signaling pathways through G-protein-coupled receptor 14 (GPR14) also known as urotensin receptor (UTR). Urotensin-II is the most potent endogenous...
7.
Rex D, Subbannayya Y, Modi P, Palollathil A, Gopalakrishnan L, Bhandary Y, et al.
Cells
. 2022 Jan;
11(1).
PMID: 35011700
Interleukin-33 (IL-33), a member of the IL-1 superfamily cytokines, is an endogenous danger signal and a nuclear-associated cytokine. It is one of the essential mediators of both innate and adaptive...
8.
Revikumar A, Kashyap V, Palollathil A, Aravind A, Raguraman R, Kumar K, et al.
J Cell Commun Signal
. 2021 Jul;
16(1):129-135.
PMID: 34309794
The G-quadruplexes (G4s) are a class of DNA secondary structures with guanine rich DNA sequences that can fold into four stranded non-canonical structures. At the genomic level, their pivotal role...
9.
Aravind A, Palollathil A, Rex D, Kumar K, Vijayakumar M, Shetty R, et al.
J Cell Commun Signal
. 2021 Jul;
16(2):293-300.
PMID: 34196939
The C-C Motif Chemokine Ligand 18 (CCL18) is a beta-chemokine sub-family member with immunomodulatory functions in primates. CCL18-dependent migration and epithelial-to-mesenchymal transition of oral squamous cell carcinoma, squamous cell carcinoma...
10.
Palollathil A, Aravind A, Vijayakumar M, Kotimoole C, Mohanty V, Behera S, et al.
OMICS
. 2021 Jun;
25(7):450-462.
PMID: 34191607
Oral cancer is common worldwide but lacks robust diagnostics and therapeutics. Lifestyle factors, such as tobacco chewing and smoking, are significantly associated with oral cancers. Mapping the changes in the...